Robert A. Kleczynski - 30 Jun 2023 Form 3 Insider Report for EXELON CORP (EXC)

Role: SVP & Corp Controller
Signature: Elizabeth M. Hensen, Attorney-in-Fact for Robert A Kleczynski
Issuer symbol: EXC
Transactions as of: 30 Jun 2023
Net transactions value: $0
Form type: 3
Filing time: 03 Jul 2023, 14:14:51 UTC
Next filing: 17 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	EXC	Common Stock						17,068	30 Jun 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	EXC	Restricted Stock Unit Award (01/25/2021)							30 Jun 2023	Common stock	1,348		Direct	F1
holding	EXC	Restricted Stock Unit Award (01/28/2022							30 Jun 2023	Common stock	2,327		Direct	F2
holding	EXC	Restricted Unit Award (01/23/2023)Stock							30 Jun 2023	Common stock	3,536		Direct	F3
holding	EXC	Restricted Stock Unit Award (02/25/2022)							30 Jun 2023	Common stock	20,990		Direct	F4
holding	EXC	Deferred Compensation Phantom Share Equivalents							30 Jun 2023	Common stock	1,438		Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Remaining 1/3 increment of annual restricted stock unit (RSU) award granted in January 2021 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Award balances accrue additional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award.
F2	Remaining 2/3 increment of annual RSU award granted in January 2022 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Award balances accrue additional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award.
F3	Annual RSU award granted in January 2023 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Award balances accrue additional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award.
F4	Restricted stock unit award granted pursuant to the Exelon Long Term Incentive Plan. Award balance accrues additional units through automatic dividend reinvestment and all shares will cliff vest on February 25, 2025 with each RSU representing the right to receive one share of Exelon common stock upon vesting.
F5	Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short-term investments. Units of the fund will be settled upon the reporting person's separation from the company for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate due to periodic changes in the fund composition.